NIOX: NIOX Group Plc - Summary | Jitta

NIOX Group Plc

LON:NIOX

Price
£0.57
Loss Chance
42.5%
6.70JITTA SCORE
12.76%Under Jitta Line
Jitta Ranking
206 / 877
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (67)
Recent Business Performance (77)
Financial Strength (76)
Return to Shareholders (28)
Competitive Advantage (74)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing Every Year
Revenue and EarningEarning loss detected in 2022
Key Stats
Jitta Score
Jitta Line
6.70
12.76%
3.28
141.83%
Health Care Equipment
2.62
923.13%
1.12
100.00%
2.85
100.00%
COMPANY DESCRIPTION
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.